Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate...

Descripción completa

Detalles Bibliográficos
Autores principales: Makker, Vicky, Colombo, Nicoletta, Herráez, Antonio Casado, Monk, Bradley J., Mackay, Helen, Santin, Alessandro D., Miller, David S., Moore, Richard G., Baron-Hay, Sally, Ray-Coquard, Isabelle, Ushijima, Kimio, Yonemori, Kan, Kim, Yong Man, Guerra Alia, Eva M., Sanli, Ulus A., Bird, Steven, Orlowski, Robert, McKenzie, Jodi, Okpara, Chinyere, Barresi, Gianmaria, Lorusso, Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
CLINICAL TRIAL UPDATES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414727/
https://www.ncbi.nlm.nih.gov/pubmed/37058687
http://dx.doi.org/10.1200/JCO.22.02152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414727/
https://www.ncbi.nlm.nih.gov/pubmed/37058687
http://dx.doi.org/10.1200/JCO.22.02152

Ejemplares similares